JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GAN
5926
DELISTED
GAN Ltd
GAN
| $7K | ﹤0.01% |
5,136
+5,000
| +3,676% | +$9.1K |
2020 Q2
11 quarters
|
|
5927
CALL
Southwest Airlines
LUV
$20.5B
| $7K | ﹤0.01% |
200
-143,600
| -100% | -$4.88M |
2022 Q3
2 quarters
|
|
|
MHUA
5928
DELISTED
Meihua International Medical Technologies
MHUA
| $7K | ﹤0.01% |
10
-2
| -17% | -$3.3K |
2022 Q4
1 quarter
|
|
5929
Rani Therapeutics
RANI
$89.7M
| $7K | ﹤0.01% |
1,443
+654
| +83% | +$3.93K |
2021 Q4
5 quarters
|
|
5930
PUT
Teck Resources
TECK
$33.5B
| $7K | ﹤0.01% |
200
-8,200
| -98% | -$325K |
2022 Q2
3 quarters
|
|
5931
Motley Fool 100 Index ETF
TMFC
$2.14B
| $7K | ﹤0.01% |
200
| – | – |
2021 Q4
5 quarters
|
|
5932
ProShares UltraPro Short 20+ Year Treasury
TTT
$28.6M
| $7K | ﹤0.01% |
+120
| New | +$7.85K |
2023 Q1
0 quarters
|
|
5933
State Street SPDR S&P Global Dividend ETF
WDIV
$276M
| $7K | ﹤0.01% |
117
+50
| +75% | +$3K |
2014 Q3
34 quarters
|
|
5934
PUT
Zoom
ZM
$27.4B
| $7K | ﹤0.01% |
100
-5,800
| -98% | -$418K |
2021 Q3
6 quarters
|
|
|
TBCH
5935
CALL
Turtle Beach Corp
TBCH
$249M
| $7K | ﹤0.01% |
+700
| New | +$5.94K |
2023 Q1
0 quarters
|
|
|
MRTX
5936
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7K | ﹤0.01% |
200
-297,300
| -100% | -$13.4M |
2021 Q2
7 quarters
|
|
|
PRTK
5937
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $7K | ﹤0.01% |
2,743
+1,107
| +68% | +$2.19K |
2016 Q4
25 quarters
|
|
|
MLVF
5938
DELISTED
Malvern Bancorp, Inc.
MLVF
| $7K | ﹤0.01% |
469
| – | – |
2017 Q4
21 quarters
|
|
|
MNTV
5939
CALL
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $7K | ﹤0.01% |
+800
| New | +$6.28K |
2023 Q1
0 quarters
|
|
5940
Amplify Seymour Cannabis ETF
CNBS
$70.2M
| $6.72K | ﹤0.01% |
133
| – | – |
2022 Q4
1 quarter
|
|
5941
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$286M
| $6.63K | ﹤0.01% |
163
+102
| +167% | +$4.1K |
2022 Q4
1 quarter
|
|
|
CYA
5942
DELISTED
Simplify Tail Risk Strategy ETF
CYA
| $6.57K | ﹤0.01% |
35
-232
| -87% | -$49.8K |
2022 Q4
1 quarter
|
|
5943
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$197M
| $6.24K | ﹤0.01% |
221
| – | – |
2022 Q4
1 quarter
|
|
5944
AC Immune
ACIU
$271M
| $6K | ﹤0.01% |
2,732
| – | – |
2020 Q4
9 quarters
|
|
5945
Alvotech
ALVO
$2.21B
| $6K | ﹤0.01% |
+499
| New | +$6.38K |
2023 Q1
0 quarters
|
|
5946
Bit Digital
BTBT
$555M
| $6K | ﹤0.01% |
3,575
-1,255
| -26% | -$1.6K |
2021 Q4
5 quarters
|
|
5947
CXApp Inc Warrant
CXAIW
$615K
| – | – |
0
| – | – |
2021 Q1
8 quarters
|
|
|
DBL
5948
DoubleLine Opportunistic Credit Fund
DBL
$268M
| $6K | ﹤0.01% |
+448
| New | +$6.69K |
2023 Q1
0 quarters
|
|
|
EMD
5949
Western Asset Emerging Markets Debt Fund
EMD
$531M
| $6K | ﹤0.01% |
+664
| New | +$6.05K |
2023 Q1
0 quarters
|
|
5950
Fidelity Dividend ETF for Rising Rates
FDRR
$757M
| $6K | ﹤0.01% |
150
-50
| -25% | -$2.03K |
2022 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.